Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Medulloblastoma 4Neuroblastoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Hypopharyngeal Neoplasms 2Ganglioneuroblastoma 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Vaginal Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1

Interventions

Radiotherapy 2Radiation 2Paclitaxel 2Cisplatin 2Carboplatin 2Brachytherapy 2Taxes 1Standard of Care 1Practice Guidelines as Topic 1Platinum 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Endometrial Clear Cell Adenocarcinoma × Platinum × Clear all
NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡